US Patent

US10130592 — Epinephrine formulations

Formulation · Assigned to Par Pharmaceuticals Inc · Expires 2035-03-13 · 9y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects pharmaceutical compositions of epinephrine, including various additives, and methods for making and administering them.

USPTO Abstract

Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.

Drugs covered by this patent

Patent Metadata

Patent number
US10130592
Jurisdiction
US
Classification
Formulation
Expires
2035-03-13
Drug substance claim
No
Drug product claim
Yes
Assignee
Par Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.